Exela Technologies Partners with McKesson Specialty Health

Global business process automation leader, Exela Technologies (NASDAQ:XELA) announced that it was selected by McKesson Specialty Health to provide a suite of business management tools to streamline claims processing.

The company said that the tools that will be provided to McKesson will range from enrollments and claims processing to adjudication and payment/copay services.

As quoted in the press release:

Individual drug requirements along with enrollment and adjudication programs have strict guidelines that are unique to each pharmaceutical copay program and specific medication. Exela’s proprietary platform, PCH Global, adheres to these guidelines and renders the program to each individual requirement. With decades of experience in the healthcare industry, the Exela solution was chosen after demonstrating the capability to adapt and service the needs of hospitals, clinics, doctors and patients.

Each program Exela designs is custom to the pharmaceutical copay program and each specific drug used by the provider, and offers the solutions provider the flexibility to adapt quickly to the ongoing and changing business requirements.

“McKesson was seeking a responsive vendor that could deliver an end-to-end solution and be able to adapt and render the program to the individual drug requirements, leading to increased customer satisfaction,” said Suresh Yannamani, President, Exela Technologies. “We are pleased to partner with McKesson, and to leverage our key technology-enabled solutions to implement this program.”

“The patient needs faster access to innovative drugs, and complicated claims management can be time consuming and hinder that process,” said Bill Nolan, Vice President and General Manager, McKesson Specialty Health. “This solution streamlines the entire process and helps drug manufacturers in their effort to remain compliant, giving peace of mind to both our team and the patients.”

Click here for the full text release.